Literature DB >> 20107228

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms.

Anthony Green, Philip Beer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20107228     DOI： 10.1056/NEJMc0910063

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   176.079


× No keyword cloud information.
  111 in total

1.  An in vivo patient-derived model of endogenous IDH1-mutant glioma.

Authors:  H Artee Luchman; Owen D Stechishin; N Ha Dang; Michael D Blough; Charles Chesnelong; John J Kelly; Stephanie A Nguyen; Jennifer A Chan; Aalim M Weljie; J Gregory Cairncross; Samuel Weiss
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

2.  IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody.

Authors:  Mindaugas Andrulis; David Capper; Jochen Meyer; Roland Penzel; Christian Hartmann; Hanswalter Zentgraf; Andreas von Deimling
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

Review 3.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

Review 4.  Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.

Authors:  Hideki Muramatsu; Hideki Makishima; Jaroslaw P Maciejewski
Journal:  Semin Oncol       Date:  2012-02       Impact factor: 4.929

Review 5.  Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond.

Authors:  Alfonso Quintás-Cardama; Hagop Kantarjian; Jorge Cortes; Srdan Verstovsek
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

6.  Inherited predisposition to myeloproliferative neoplasms.

Authors:  Amy V Jones; Nicholas C P Cross
Journal:  Ther Adv Hematol       Date:  2013-08

Review 7.  Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs).

Authors:  Wenyi Luo; Zhongxin Yu
Journal:  Stem Cell Investig       Date:  2015-08-31

8.  Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation.

Authors:  Jelena Lazovic; Horacio Soto; David Piccioni; Jerry R Lou; Sichen Li; Leili Mirsadraei; William Yong; Robert Prins; Linda M Liau; Benjamin M Ellingson; Timothy F Cloughesy; Albert Lai; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

Review 9.  Prognosis of Primary Myelofibrosis in the Genomic Era.

Authors:  Prithviraj Bose; Srdan Verstovsek
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08

10.  Epigenetic therapy of hematological malignancies: where are we now?

Authors:  Relja Popovic; Mrinal Y Shah; Jonathan D Licht
Journal:  Ther Adv Hematol       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.